Meijer A, Verheugt F W, van Eenige M J, Werter C J
Department of Cardiology, Free University Hospital, Amsterdam, The Netherlands.
Circulation. 1994 Oct;90(4):1706-14. doi: 10.1161/01.cir.90.4.1706.
After successful thrombolysis for acute myocardial infarction, reocclusion is observed in about 30% of patients after 3 months and usually occurs without reinfarction. We studied the impact of reocclusion without reinfarction on global and regional left ventricular function and on remodeling during that period.
The patients for this analysis constituted a subset of those enrolled in the APRICOT-trial, which was designed to study the efficacy of antithrombotics on the prevention of reocclusion. Patients were selected who had a left anterior descending- or right coronary artery-related myocardial infarction, had an angiographically patent infarct-related vessel when studied < 48 hours after intravenous thrombolysis, and underwent repeat cardiac catheterization at 3 months. Paired contrast ventriculograms of quality sufficient to analyze regional wall motion, global ejection fraction, and ventricular volumes were analyzed in 129 patients. Enzymatic infarct size and baseline left ventricular function as well as other baseline characteristics were similar in patients with (n = 34) and without (n = 95) reocclusion. Ejection fraction improved in anterior infarction without reocclusion from 47 +/- 10% to 54 +/- 13% (P = .0001) but not with reocclusion (baseline, 48 +/- 13%; 3 months, 48 +/- 16%). No improvement was seen in inferior infarction with or without reocclusion. Persistent patency allowed preservation of end-systolic volume index (ESVI) at 3 months (37 +/- 14 mL/m2) to baseline level (38 +/- 13 mL/m2), with a better chance for improvement of > 10 mL/m2 without reocclusion in those with baseline values > 40 mL/m2. After reocclusion, in contrast, ESVI increased from 37 +/- 14 to 43 +/- 20 mL/m2 (P = .08). Comparable mean changes of ESVI in response to persistent patency or reocclusion were seen in anterior versus inferior infarction. Recovery of infarct zone contractility was impaired by reocclusion, both in terms of abnormality of segment shortening and expressed in the number of segments showing abnormal wall motion. In anterior but not in inferior infarction, infarct zone contractility was better with good collaterals to the reoccluded artery compared with poor collaterals.
After successful thrombolysis for acute myocardial infarction, reocclusion without reinfarction withholds salvaged myocardium from regaining contractility. This has deleterious consequences for regional and global left ventricular function and for remodeling. To further optimize prognosis in patients after thrombolysis, future research should focus on the prevention of reocclusion and should evaluate revascularization therapy in patients with reocclusion.
急性心肌梗死成功溶栓后,约30%的患者在3个月后出现再闭塞,且通常不伴有再梗死。我们研究了无再梗死的再闭塞对该时期左心室整体和局部功能以及重构的影响。
本分析的患者构成了APRICOT试验入选患者的一个子集,该试验旨在研究抗栓药物预防再闭塞的疗效。入选的患者为左前降支或右冠状动脉相关的心肌梗死患者,在静脉溶栓后<48小时进行研究时梗死相关血管造影显示通畅,并在3个月时接受重复心脏导管检查。对129例患者的配对对比心室造影进行分析,其质量足以分析局部壁运动、整体射血分数和心室容积。有再闭塞(n = 34)和无再闭塞(n = 95)的患者在酶学梗死面积、基线左心室功能以及其他基线特征方面相似。前壁梗死无再闭塞患者的射血分数从47±10%提高到54±13%(P = .0001),而有再闭塞的患者未提高(基线为48±13%;3个月时为48±16%)。下壁梗死无论有无再闭塞均未见改善。梗死相关血管持续通畅可使3个月时的收缩末期容积指数(ESVI)(37±14 mL/m²)维持在基线水平(38±13 mL/m²),对于基线值>40 mL/m²的患者,无再闭塞时改善>10 mL/m²的机会更大。相比之下,再闭塞后ESVI从37±14增加到43±20 mL/m²(P = .08)。前壁梗死和下壁梗死在对梗死相关血管持续通畅或再闭塞的反应中,ESVI的平均变化相当。再闭塞损害了梗死区域收缩力的恢复,这在节段缩短异常方面以及表现为壁运动异常的节段数量方面均有体现。在前壁梗死而非下壁梗死中,与侧支循环不良相比,再闭塞动脉的侧支循环良好时梗死区域收缩力更好。
急性心肌梗死成功溶栓后,无再梗死的再闭塞使挽救的心肌无法恢复收缩力。这对左心室局部和整体功能以及重构产生有害影响。为进一步优化溶栓后患者的预后,未来研究应聚焦于预防再闭塞,并应评估再闭塞患者的血运重建治疗。